Inhibiting the renin-angiotensin system in patients with type 1 diabetes: is it worth it?

被引：0
|
作者：
Duka, Irena [1 ]
Bakris, George [1 ]
机构：
[1] Univ Chicago, Med Ctr, Hypertens Dis Unit, Pritzker Sch Med,Dept Med, Chicago, IL 60637 USA
来源：
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE | 2009年 / 119卷 / 11期
关键词：
BLOOD-PRESSURE CONTROL; RENAL OUTCOMES; HYPERTENSION; RETINOPATHY; VEGF; NEPHROPATHY; PROGRESSION; PREVENTION; LOSARTAN; MELLITUS;
D O I：
10.20452/pamw.809
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：692 / 693
页数：2
相关论文
共 50 条
  • [1] Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus
    Hollenberg, NK
    Price, DA
    Fisher, NDL
    Lansang, MC
    Perkins, B
    Gordon, MS
    Williams, GH
    Laffel, LMB
    KIDNEY INTERNATIONAL, 2003, 63 (01) : 172 - 178
  • [2] Inhibiting the renin-angiotensin system: Why and in which patients
    Berra, Kathy
    Miller, Nancy Houston
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2009, 21 (01): : 66 - 75
  • [3] Diabetes: Early blockade of the renin-angiotensin system in type 1 diabetes mellitus
    Vig J.
    Nature Reviews Endocrinology, 2009, 5 (12) : 640 - 640
  • [4] DRUGS INHIBITING THE RENIN-ANGIOTENSIN SYSTEM
    ANTONACCIO, MJ
    CUSHMAN, DW
    FEDERATION PROCEEDINGS, 1981, 40 (08) : 2275 - 2284
  • [5] Renin-Angiotensin System in Diabetes
    Rein, Johannes
    Bader, Michael
    PROTEIN AND PEPTIDE LETTERS, 2017, 24 (09): : 833 - 840
  • [6] The Renin-Angiotensin System in the Pathophysiology of Type 2 Diabetes
    Goossens, Gijs H.
    OBESITY FACTS, 2012, 5 (04) : 611 - 624
  • [7] EFFECT OF DAPAGLIFLOZIN ON ALBUMINURIA AND THE RENIN-ANGIOTENSIN SYSTEM WHEN ADDED TO RENIN-ANGIOTENSIN BLOCKADE IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY
    Eickhoff, Mie
    Frimodt-Moller, Marie
    Jorgensen, Niklas Rye
    Rossing, Peter
    Persson, Frederik
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [8] Inhibition of the renal renin-angiotensin system and renoprotection by pitavastatin in type 1 diabetes
    Toba, Hiroe
    Mitani, Takuya
    Takahashi, Tamotsu
    Imai, Nobuyoshi
    Serizawa, Ryoko
    Wang, Jiahong
    Kobara, Miyuki
    Nakata, Tetsuo
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (11): : 1064 - 1070
  • [9] The renin-angiotensin system and diabetes: An update
    Ribeiro-Oliveira, Antonio, Jr.
    Nogueira, Anelise Impeliziere
    Pereira, Regina Maria
    Vilas Boas, Walkiria Wingester
    Souza dos Santos, Robson Augusto
    Simoes e Silva, Ana Cristina
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (04) : 787 - 803
  • [10] Renin-angiotensin system gene polymorphisms and retinopathy in Chinese patients with type 2 diabetes
    Thomas, GN
    Critchley, JAJH
    Tomlinson, B
    Yeung, VTF
    Lam, D
    Cockram, CS
    Chan, JCN
    DIABETES CARE, 2003, 26 (05) : 1643 - 1644
12345